Literature DB >> 9832465

Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin.

M Nakazato1, H Yamaguchi, Y Date, M Miyazato, K Kangawa, M F Goy, N Chino, S Matsukura.   

Abstract

Uroguanylin, a member of the guanylin peptide family, acts on guanylyl cyclase C (GC-C) to regulate intestinal and renal fluid and electrolyte transport through the second messenger, cGMP. Using an antiserum raised against synthetic rat uroguanylin, we established an RIA and identified three endogenous molecular forms in the intestine and kidney: a 15-amino acid uroguanylin, an 18-amino acid uroguanylin that is a monobasic processing product, and a 9.4-kDa prouroguanylin. Prouroguanylin is the major molecular form in these two tissues, whereas only 15-amino-acid uroguanylin is present in the urine. Rat uroguanylin is most abundant in the proximal small intestine, its content decreasing toward the colon. Uroguanylin is present immunohistochemically in the endocrine cells in the intestine and stomach, B cells in the pancreatic islets, and tubular epithelial cells in the kidney. Uroguanylin has a widespread tissue distribution and is located in cells that function in an endocrine, paracrine, and/or luminocrine (luminal secretion) fashion. Uroguanylin may have physiological functions other than the regulation of fluid and electrolyte transport in the intestine and kidney.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832465     DOI: 10.1210/endo.139.12.6347

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.

Authors:  C Folgueira; E Sanchez-Rebordelo; S Barja-Fernandez; R Leis; S Tovar; F F Casanueva; C Dieguez; R Nogueiras; L M Seoane
Journal:  Eur J Nutr       Date:  2015-03-06       Impact factor: 5.614

Review 2.  Mechanisms of actions of guanylin peptides in the kidney.

Authors:  Aleksandra Sindić; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

3.  Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert C Fellner; Christopher Cazzolla; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

4.  The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Bonnie Taylor-Blake; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

5.  Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.

Authors:  John N Lorenz; Michelle Nieman; Jenine Sabo; L Philip Sanford; Jennifer A Hawkins; Noeet Elitsur; Lara R Gawenis; Lane L Clarke; Mitchell B Cohen
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 6.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

7.  Occurrence and localization of uroguanylin in the aging human prostate.

Authors:  Caroline Maake; Franziska Auf der Maur; Katarina Jovanovic; Manfred Reinecke; Dieter Hauri; Hubert John
Journal:  Histochem Cell Biol       Date:  2002-12-21       Impact factor: 4.304

8.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

9.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

Review 10.  Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.

Authors:  Erik S Blomain; Dante J Merlino; Amanda M Pattison; Adam E Snook; Scott A Waldman
Journal:  Mol Pharmacol       Date:  2016-06-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.